MedTech News
.................... by Andrew Celentano
Signos gets FDA green light for over-the-counter CGM for weight management
Signos today announced a major step forward in bringing over-the-counter (OTC) continuous glucose monitoring (CGM) to market.
Microbot Medical earns new surgical robot patent
Microbot Medical (Nasdaq:MBOT) announced today that it received a new patent covering a modular robotic surgical system.
Innovation in the Fight Against Parkinson’s: Stimvia’s Non-Invasive URIS® Therapy Shows Success in Clinical Study
OSTRAVA, Czech Republic, Aug. 19, 2025 /PRNewswire/ — Stimvia, a medtech company based in the Czech Republic, has successfully completed a clinical study on peroneal electrical transcutaneous neuromodulation (peroneal eTNM®) through its URIS® device to treat Parkinson’s disease symptoms.
DTSS’s acoustic innovation addresses the healthcare application market projected to exceed $100 billion in China and approach $90 billion globally by 2030
Datasea, a Nevada-based technology enterprise specialising in advanced acoustic high-tech products and AI multimodal digital solutions, today announced a milestone breakthrough in its acoustic technology
Machine learning model maps West Nile virus risk in Northeast US
West Nile virus (WNV) has been the dominant cause of mosquito-borne illness in the United States since its introduction into North America in 1999. There are no vaccines nor medications to prevent or treat illness in people, so surveillance, prevention, and control remain the best options to protect the public.
AI hybrid strategy improves mammogram interpretation
A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection rates.
Uniquely shaped microstent developed to combat glaucoma
A team of researchers at the University of Oxford have unveiled a pioneering “microstent” which could revolutionize treatment for glaucoma, a common but debilitating condition. The study has been published in The Innovation.
Surprising gene activity shields certain nerve cells from ALS damage
By analyzing millions of messenger RNA molecules (mRNA) during the course of ALS, researchers at Stockholm University, in collaboration with scientists at the Paris Brain Institute and Örebro University, have identified why certain nerve cells are resistant to the disease and what happens in the sensitive nerve cells when they are affected.